Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,147,313
+$631,963 QoQ
Shares Held
1,840
+175.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#619
of 1,322 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. REGN ranks #56 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in REGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,147,313 | 1,840 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $515,350 | 667 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $630,617 | 817 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $459,936 | 818 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $281,400 | 536 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $336,141 | 530 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $220,822 | 310 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $325,884 | 310 | Shares | Defined | 2024-11-12 | |
| 2023-12-31 | $342,533 | 390 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $329,184 | 400 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $305,379 | 425 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $345,101 | 420 | Shares | Defined | 2023-05-10 | |
| 2022-06-30 | $309,160 | 523 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $368,765 | 528 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $359,966 | 570 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $340,716 | 563 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $220,298 | 456 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $876,055 | 1,565 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $967,280 | 1,551 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $222,171 | 455 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||